These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17567694)

  • 21. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling.
    Tan SL; Nakao H; He Y; Vijaysri S; Neddermann P; Jacobs BL; Mayer BJ; Katze MG
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5533-8. PubMed ID: 10318918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C Virus Proteins Core and NS5A Are Highly Sensitive to Oxidative Stress-Induced Degradation after eIF2α/ATF4 Pathway Activation.
    Ríos-Ocampo WA; Navas MC; Buist-Homan M; Faber KN; Daemen T; Moshage H
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32283772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between hyporesponsiveness to Toll-like receptor ligands and liver dysfunction in patients with chronic hepatitis C virus infection.
    Chung H; Watanabe T; Kudo M; Chiba T
    J Viral Hepat; 2011 Oct; 18(10):e561-7. PubMed ID: 21914077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation.
    Dolganiuc A; Kodys K; Kopasz A; Marshall C; Do T; Romics L; Mandrekar P; Zapp M; Szabo G
    J Immunol; 2003 Jun; 170(11):5615-24. PubMed ID: 12759441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease.
    Negash AA; Ramos HJ; Crochet N; Lau DT; Doehle B; Papic N; Delker DA; Jo J; Bertoletti A; Hagedorn CH; Gale M
    PLoS Pathog; 2013; 9(4):e1003330. PubMed ID: 23633957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus: the role of molecular mimicry in response to interferon treatment.
    Uzicanin S; Hu YW; Alsousi H; Pelchat M; Rocheleau L; Nair RC; Brown EG
    J Med Virol; 2012 Oct; 84(10):1571-85. PubMed ID: 22930505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class A Scavenger Receptor-Mediated Double-Stranded RNA Internalization Is Independent of Innate Antiviral Signaling and Does Not Require Phosphatidylinositol 3-Kinase Activity.
    Nellimarla S; Baid K; Loo YM; Gale M; Bowdish DM; Mossman KL
    J Immunol; 2015 Oct; 195(8):3858-65. PubMed ID: 26363049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
    Johnson CL; Owen DM; Gale M
    J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of Hepatitis C virus proteins with pattern recognition receptors.
    Imran M; Waheed Y; Manzoor S; Bilal M; Ashraf W; Ali M; Ashraf M
    Virol J; 2012 Jun; 9():126. PubMed ID: 22726246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endotoxin-induced maturation of MyD88-deficient dendritic cells.
    Kaisho T; Takeuchi O; Kawai T; Hoshino K; Akira S
    J Immunol; 2001 May; 166(9):5688-94. PubMed ID: 11313410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon.
    Chattergoon MA; Latanich R; Quinn J; Winter ME; Buckheit RW; Blankson JN; Pardoll D; Cox AL
    PLoS Pathog; 2014 May; 10(5):e1004082. PubMed ID: 24788318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.
    Feng CG; Scanga CA; Collazo-Custodio CM; Cheever AW; Hieny S; Caspar P; Sher A
    J Immunol; 2003 Nov; 171(9):4758-64. PubMed ID: 14568952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
    Fukuma T; Enomoto N; Marumo F; Sato C
    Hepatology; 1998 Oct; 28(4):1147-53. PubMed ID: 9755255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
    Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
    Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonstructural 5A Protein of Hepatitis C Virus Interferes with Toll-Like Receptor Signaling and Suppresses the Interferon Response in Mouse Liver.
    Tsutsumi T; Okushin K; Enooku K; Fujinaga H; Moriya K; Yotsuyanagi H; Aizaki H; Suzuki T; Matsuura Y; Koike K
    PLoS One; 2017; 12(1):e0170461. PubMed ID: 28107512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of intermediary domain of MyD88 in cell activation and therapeutic inhibition of TLRs.
    Avbelj M; Horvat S; Jerala R
    J Immunol; 2011 Sep; 187(5):2394-404. PubMed ID: 21804016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C Virus NS5A Targets Nucleosome Assembly Protein NAP1L1 To Control the Innate Cellular Response.
    Çevik RE; Cesarec M; Da Silva Filipe A; Licastro D; McLauchlan J; Marcello A
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28659470
    [No Abstract]   [Full Text] [Related]  

  • 39. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line.
    Wang Y; Li J; Wang X; Ye L; Zhou Y; Thomas RM; Ho W
    Innate Immun; 2014 Jan; 20(1):3-11. PubMed ID: 23529855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.